Patent details
EP3496739 Title: COMPOSITIONS COMPRISING ACTRIIA POLYPEPTIDES FOR USE IN TREATING PULMONARY HYPERTENSION
Basic Information
- Publication number:
- EP3496739
- PCT Application Number:
- US2017042157
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178285409
- PCT Publication Number:
- WO2018013936
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English Title of Invention:
- COMPOSITIONS COMPRISING ACTRIIA POLYPEPTIDES FOR USE IN TREATING PULMONARY HYPERTENSION
- French Title of Invention:
- COMPOSITIONS COMPRENANT DES POLYPEPTIDES ACTRIIA POUR LEUR UTILISATION DANS LE TRAITEMENT DE L'HYPERTENSION PULMONAIRE
- German Title of Invention:
- ZUSAMMENSETZUNGEN ENTHALTEND ACTRIIA-POLYPEPTIDE ZUR VERWENDUNG BEI DER BEHANDLUNG VON PULMONALER HYPERTONIE
- SPC Number:
-
LUC00377
Dates
- Filing date:
- 14/07/2017
- Grant date:
- 28/04/2021
- EP Publication Date:
- 19/06/2019
- PCT Publication Date:
- 18/01/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/04/2021
- EP B1 Publication Date:
- 28/04/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/07/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2025
- Name:
- ACCELERON PHARMA INC.
- Address:
- 126 East Lincoln Avenue, 07065, Rahway, New Jersey , United States (US)
History of Owners
- From:
- 21/04/2021
- To:
- 13/03/2025
- Name:
- Acceleron Pharma Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
Agent
- Name:
- STOLMÁR & PARTNER
- From:
- 28/06/2021
- Address:
- BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
- To:
Inventor
1
- Name:
- KUMAR, Ravindra
- Address:
- United States (US)
2
- Name:
- KNOPF, John
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201662362955 P
- Priority Date:
- 15/07/2016
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762453888 P
- Priority Date:
- 02/02/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762510403 P
- Priority Date:
- 24/05/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/17; A61K 47/68; A61P 7/00; A61P 11/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2025/05
- Publication date:
- 07/04/2025
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 202117
- Publication date:
- 28/04/2021
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20250000082A
- Date Registered:
- 13/03/2025
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Change of address
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- ACCELERON PHARMA INC.
- Address:
- 126 East Lincoln Avenue, 07065, Rahway, New Jersey , United States (US)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/07/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/06/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 28/06/2021 | Power Of Attorney | 2 |
| 29/06/2021 | Outgoing Correspondence | 1 |
| 13/03/2025 | Request For Change | 1 |
| 14/03/2025 | Outgoing Correspondence | 1 |